SPRO - Spero Therapeutics GAAP EPS of -$0.24 misses by $0.20 revenue of $9.26M misses by $12.27M
2024-05-15 16:10:58 ET
More on Spero Therapeutics
- Spero Therapeutics Delivers On Game Plan To Create Shareholder Value
- Spero Therapeutics, Inc. (SPRO) Q4 2023 Earnings Call Transcript
- Spero Therapeutics Q1 2024 Earnings Preview
- Spero Therapeutics Q4 2023 Earnings Preview
- Seeking Alpha’s Quant Rating on Spero Therapeutics